Albany Times Union - "Mount Sinai School of Medicine and MRC Technology To Collaborate On Monoclonal Antibody Production and Humanization"

 – April 2, 2012 /Press Release/  –– 

The Mount Sinai Medical Center and MRC Technology (MRCT), the technology transfer organization for the United Kingdom’s prestigious Medical Research Council, have reached an agreement to collaborate on the development of monoclonal antibodies that can be commercialized as drugs to control infection and treat diseases. The two-year agreement with MRCT marks the first time Mount Sinai has entered into a collaboration of this kind. Learn more